Karl‐Hermann Schlingensiepen

Statistics

Publications

Citations

1.2K

H-Index

Active since

1991

Affiliations

Max Planck Institute for Biophysical Chemistry(Current)

Max Planck Society

Immundiagnostik (Germany)

Vifor Pharma (Germany)

Goethe University Frankfurt

Karl‐Hermann Schlingensiepen is an author at Max Planck Institute for Biophysical Chemistry specializing in neuroscience, neurobiology, and molecular neuroscience.

Publications per year

1991–2011

Publications

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen et al. · Oligonucleotides · 2007 · 217 citations

Medicine, Oncology, Pharmacology +13

Transforming growth factor‐beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer

Karl‐Hermann Schlingensiepen, Frank Jaschinski, Sven Arke Lang et al. · Cancer Science · 2011 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptationsin vivo

Karl‐Hermann Schlingensiepen, Franziska Wollnik, M. Kunst et al. · Cellular and Molecular Neurobiology · 1994 · 126 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Opposite functions of Jun‐B and c‐jun in growth regulation and neuronal differentiation

Karl‐Hermann Schlingensiepen, Reimar Schlingensiepen, M. Kunst et al. · Developmental Genetics · 1993 · 92 citations

Life Sciences, Cell Biology, Genetics +10

Transforming growth factor-β-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides

Piotr Jachimczak, Birgit Hessdörfer, Klaus Fabel‐Schulte et al. · International Journal of Cancer · 1996 · 86 citations

Medicine, Cancer Biology, Oncology +16

1–5 of 21